95363 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups - in which the condensed system contains two hetero rings Bridged systems
Small molecule inhibitors targeting sporulation
#302NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#303NOVEL DERIVATIVES HAVING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFURAN MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#304BIFUNCTIONAL COMPOUNDS
#305BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
#306Polycyclic amines as sigma receptor modulators
#307METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#308SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS
#309NOVEL DERIVATIVES HAVING 1,2,3,4-TETRAHYDRONAPHTHALENE MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#310Chromatographic separation of metals using DOTA-based chelators
#311Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
#312Cycloalkyl pyrimidines as ferroportin inhibitors
#313JAK INHIBITOR COMPOUND AND USE THEREOF
#3141,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
#315HOMOPIPERAZINYL AND HOMOPIPERIDINYL QUINAZOLIN-4(3H)-ONE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN
#316SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#317SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#318Nitrogen containing bicyclic compounds
#319Heterocyclic compounds and uses thereof
#320OXO SIX-MEMBERED CYCLOPYRIMIDINE COMPOUND, PREPARATION METHOD AND MEDICAL USE THEREOF
#321Compounds and methods for modulating Interleukin-2-inducible T-cell kinase
#322TYROSINE KINASE INHIBITOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE
#323QUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
#324Kv11.1-3.1 INHIBITING METHODS AND COMPOSITIONS
#325Crystalline forms of diazabicyclooctane derivative and production process thereof
#326CXCR4 Receptor Antagonists
#327PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-PHENYL-, PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-HETEROARYL-, OR PHENYL-(1,3)DIOXO[4,5-C]PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO[D]IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME
#328PYRIDAZINONE DERIVATIVE
#3294-azaindole compounds
#330INDOLE DERIVATIVE-CONTAINING INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#331Isoquinolin-3-yl carboxamides and preparation and use thereof
#332Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists
#333INHIBITORS OF CBL-B AND METHODS OF USE THEREOF
#334Methods and compounds for restoring mutant p53 function
#335ALK-5 inhibitors and uses thereof
#336HETEROAROMATIC ACETAMIDE DERIVATIVE, AND PREPARATION AND USE THEREOF
#337SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF
#338C-carbon linked glutarimide degronimers for target protein degradation
#339COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING
#340BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
#341ALKYNYL QUINAZOLINE COMPOUNDS
#342METHOD FOR PRODUCING PHENOL DERIVATIVE
#343Diazabicyclooctanones as inhibitors of serine beta-lactamases
#3442-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors
#345SUBSTITUTED N-PHENYL URACILS, SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS
#346Compounds for the treatment of BRAF-associated diseases and disorders
#347KIF18A INHIBITORS
#348HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
#349Azabicyclo and diazepine derivatives
#350Method for producing morphinan derivative
#351INHIBITOR CONTAINING BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
#352PROGRANULIN MODULATORS AND METHODS OF USING THE SAME
#353Cycloalkyl and Heterocycloalkyl Benzisoxazole Sulfonamide Derivatives
#354CALIXARENE COMPOUNDS AND USES THEREOF
#355Compounds For Modulating FXR
#3563,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-c]pyridine compounds and medicaments using same
#357Process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
#358Curable composition, cured product, and compound
#359KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#360SMALL MOLECULE MODULATORS OF IL-17
#361OPIOID RECEPTOR MODULATOR AND USE THEREOF
#362Methods of treating sarin exposure with tetrahydrocannabinol and cannabidiol combinations
#363SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF
#364BICYCLIC ROR-GAMMA MODULATORS
#365METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS
#366Histone acetylase p300 inhibitor and use thereof
#367Preparation of seimicarbazide-sensitive amine oxidase inhibitor and use thereof
#368QUINOLINYL-PYRAZINE-CARBOXAMIDE COMPOUNDS AND USES THEREOF
#369Glucosylceramide synthase inhibitors
#370Reservoir drilling fluids consist of cationic heterocyclic polymers, synthesis, formulation, and applications
#371EBNA1 inhibitors and methods using same
#372Cathinone derivatives, pharmaceutical formulations, and methods
#373PYRIMIDINONES AS FACTOR XIA INHIBITORS
#374METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#375ADO-resistant cysteamine analogs and uses thereof
#376GLP-1R AGONISTS AND USES THEREOF
#377METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS
#378ELECTROLYTE ADDITIVE, ELECTROLYTE, LITHIUM ION SECONDARY BATTERY CONTAINING THE SAME AND USE THEREOF
#379Substituted piperidine compounds and their use
#380LOX INHIBITORS
#381Quinolinone and benzoxazine derivatives as muscarinic Mand/or Mreceptor agonists
#382Annulation catalysts via direct C—H bond amination
#383Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
#3842-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors
#385MODULATORS OF THE INTEGRATED STRESS PATHWAY
#386Inhibitors of integrin alpha 2 beta 1 and methods of use
#3872-heteroaryl aminoquinazolinone derivative
#3882-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS
#389Phenyltetrazole derivatives as plasma kallikrein inhibitors
#390Hormone receptor modulators for treating metabolic mutagenic and fibrotic conditions and disorders
#391Multicyclic compounds as farnesoid X receptor modulators
#392Substituted alkynylene compounds as anticancer agents
#393TARGETED NITROXIDE AGENTS
#394Processes for preparing a diazabicyclooctane compound
#395CXCR4 INHIBITORS AND USES THEREOF
#396Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation
#397Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched PCTA and synthesis method
#398Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
#399Pyrazolopyridine compounds for the treatment of autoimmune disease
#400Morphinan compounds
#401Benzothiazole compounds for the treatment of autoimmune diseases
#402PYRROLIDINYL AMIDE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
#403INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
#404Methods and compositions for substituted arylcycloheptane analogs
#405Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators
#406NEW BETA-LACTAMASE INHIBITORS TARGETING GRAM NEGATIVE BACTERIA
#407Inhibitors of (α-v)(β-6) integrin
#408Methods for treating Huntington's disease
#409Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof
#410INHIBITORS OF SARM1
#411MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE
#412METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#413PYRROLIDINE AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
#414SUBSTITUTED 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
#415CRYSTALLINE FORMS OF 3-((1R,5S,9r)-9-ETHOXY-3-AZABICYCLO[3.3.1]NONAN-9-YL)-BENZAMIDE AND SALT FORMS THEREOF
#416Thyroid hormone receptor agonists and use thereof
#4171,4-substituted piperidine derivatives
#418SIGMA-2 RECEPTOR LIGAND DRUG CONJUGATES AS ANTITUMOR COMPOUNDS, METHODS OF SYNTHESIS AND USES THEREOF
#419ABHD12 inhibitors and methods of making and using same
#4203,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same
#421Gadolinium bearing PCTA-based contrast agents
#422SOS1 inhibitors
#423ATM kinase inhibitors and compositions and methods of use thereof
#424Azabicyclo and diazepine derivatives
#425Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
#426Methods and compositions for modulating splicing
#427Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
#428Tropomyosin-related kinase (TRK) inhibitors
#429Tyrosine kinase inhibitor compositions, methods of making and methods of use
#430Benzimidazolone derived inhibitors of BCL6
#431Heterocyclic RIP1 inhibitory compounds
#432Cathepsin C inhibitors
#433Aryl and heteroaryl substituted indole compounds
#434THERAPEUTIC COMPOUNDS
#435Therapeutic compounds and methods of use thereof
#436Apelin receptor (APJ) agonists and uses thereof
#437Substituted indole ether compounds
#438INHIBITORS OF BRUTONS TYROSINE KINASE
#439Heterocyclic RIP1 kinase inhibitors
#440RIP1 inhibitory compounds and methods for making and using the same
#441RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#442Modulators of complex I
#443Urea-glyoxal crosslinking compounds for phenolic binder compositions
#444Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
#445TRNA synthetase inhibitors
#446Bicyclic RORγ modulators
#447Acryloyl-containing nuclear transport regulators and uses thereof
#448SREBP inhibitors comprising a 6-membered central ring
#449Compounds useful as inhibitors of ATR kinase
#450Crystalline forms of CFTR modulators
#451Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
#452Heterocyclic P2Yreceptor antagonists
#4532,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
#454Beta-lactamase inhibitor and use thereof
#455Morphinan derivative
#456Imidazole and triazole containing bicyclic compounds as JAK inhibitors
#45710H-phenothiazine ferroptosis inhibitor as well as the preparative method and the use thereof
#458β-lactamase inhibitor and use thereof
#459Compounds for binding proprotein convertase subtilisin/kexin type 9
#460Compounds for treating Huntington's disease
#461FXR agonist
#462PD-1/PD-L1 inhibitors
#463Pyclen-based macrocyclic ligands, chelates thereof and uses thereof
#464Short conjugated oligoelectrolytes and uses thereof
#465Pan-tropic entry inhibitors
#466HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS
#467Pyrazole derivative compound and use thereof
#468Compounds for treating huntington's disease
#469Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors
#470SUPER-OXIDE DISMUTASE MIMETICS
#471Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors
#472Indazole compounds and uses thereof
#473Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#474TLR7/8 ANTAGONISTS AND USES THEREOF
#475TLR7/8 antagonists and uses thereof
#476Substituted benzodiazoles and use thereof in therapy
#477Process for producing fluorinated compounds using alcohol solvent having unsaturated hydrocarbon
#478Inhibitors of protein arginine methyltransferase 5 (PRMT5), pharmaceutical products thereof, and methods thereof
#479METHOD FOR PURIFYING 2-[[2-[[[3-(4-CHLOROPHENYL)-8-METHYL-8-AZABICYCLO-[3.2.1]-OCT-2-YL]METHYL](2-MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOL-[1R-(EXO-EXO)]TRIHYDROCHLORIDE
#480Crystal form of β-lactamase inhibitor and preparation method therefor
#481Cannabinoid co-drug compounds
#482MORPHINAN DERIVATIVES AND USE THEREOF
#483NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
#4842-(1H-pyrazol-3-yl) phenol compound and use thereof
#485Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors
#486Process for the preparation of umeclidinium bromide
#4871,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions
#488Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
#489Methods of synthesizing aztreonam derivatives
#490Pyrimidine JAK inhibitors for the treatment of skin diseases
#491NEW ANTIBIOTICS TARGETING MYCOBACTERIA
#492Quinolone compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders
#493TARGETED NITROXIDE AGENTS
#494sGC stimulators
#495Organic electroluminescent materials and devices
#496FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2
#497Compounds and compositions as modulators of TLR signaling
#498MYC G-quadruplex stabilizing small molecules and their use
#499Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity
#500Piperazine derivatives as MAGL inhibitors
#501Isoquinolin-3-YL carboxamides and preparation and use thereof
#502BETA-LACTAMASE INHIBITORS AND USES THEREOF
#503Chemical compounds
#504Crystalline form of an avibactam derivative
#505Sulfonamide carboxamide compounds
#506Imidazole-pyrazole derivatives
#507Alkene compounds as farnesoid x receptor modulators
#508Muscarinic agonists as non-steroidal and non-opioid analgesics and methods of use thereof
#509GLP-1R agonists and uses thereof
#510Metallo-beta-lactamase inhibitors and methods of use thereof
#511Methods and compositions for modulating splicing
#512Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
#5131,5,7-TRISUBSTITUTED ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF IN MEDICINES
#514CXCR4 inhibitors and uses thereof
#515Methods and compositions for modulating splicing
#516Compounds, compositions and methods for treatment of myopia
#517Imaging composition and uses thereof
#518EBNA1 inhibitors and methods using same
#519Imidazole and triazole containing bicyclic compounds as JAK inhibitors
#520Compositions and uses thereof
#521Methods and compositions for modulating splicing
#522Benzodiazepine derivatives as RSV inhibitors
#523Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds
#524COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
#525Biheteroaryl compounds and uses thereof
#526Crystalline forms of diazabicyclooctane derivative and production process thereof
#527Pharmaceutical compound
#528BIHETEROARYL COMPOUNDS AND USES THEREOF
#5293,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents
#530PD-1/PD-L1 inhibitors
#531Inhibitors of (α-v)(β-6) integrin
#532HISTONE DEACETYLASE INHIBITORS
#533Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof
#534LIGAND COMPOUND OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AND APPLICATION THEREOF
#535Englerin derivatives for treatment of cancer
#536Compounds useful as inhibitors of ATR kinase
#5372-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors
#538METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#5391,3-thiazol-2-yl substituted benzamides
#540Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
#541Macrocyclic ligands with picolinate group(s), complexes thereof and also medical uses thereof
#542Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synthesis and uses thereof
#543ANTIVIRAL COMPOUNDS
#544Substituted methanopyrido [2, 1-a] isoindolones as mAChR modulators for treating various associated pathophysiological conditions and process for preparation thereof
#545Methods for treating Huntington's disease
#546Derivatives of relebactam and uses thereof
#5474-Azaindole compounds
#548Inhibitors of (alpha-v)(beta-6) integrin
#549Morphinan derivative
#550Tyrosine amide derivatives as Rho-Kinase inhibitors
#5511,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
#552Selective NR2B antagonists
#553Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
#554KRAS G12C inhibitors and methods of using the same
#555Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#556Pyrimidinones as factor XIA inhibitors
#557Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereof
#558Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
#559Processes for preparing a diazabicyclooctane compound
#560Beta-lactamase inhibitors and uses thereof
#561Hydrocodone base and methods for its purification
#562COMPOSITION COMPRISING ANTIBIOTIC COMPOUND AND AN HETEROCYCLIC COMPOUND AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
#563Morphinan compounds
#564NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
#565NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
#566PD-1/PD-L1 inhibitors
#567PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#568β-lactamase inhibitors
#569Nanohoop compound embodiments comprising meta-substitution and molecular systems comprising the same
#570Imaging composition and uses thereof
#571Heterocyclic derivatives for the treatment of cystic fibrosis
#572Heterocyclic compounds useful as Pim kinase inhibitors
#573Substituted glycine derived FXIA inhibitors
#5741,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
#575Compounds and methods for modulating interleukin-2-inducible t-cell kinase
#576Substituted Heterocyclic Compounds as Inhibitors of PRDM9
#577HETEROCYCLIC COMPOUNDS AND USES THEREOF
#578Antidiabetic heterocyclic compounds
#579Process for the preparation of crystalline form C of avibactam sodium
#5801,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#581Compounds useful as immunomodulators
#582Indolinones compounds and their use in the treatment of fibrotic diseases
#583BMP-signal-inhibiting compound
#584Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them
#585Morphinan derivatives and use thereof
#586SUPER-OXIDE DISMUTASE MIMETICS
#587Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
#588HIV inhibitor compounds
#589Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators
#590Heterocyclic compounds for the treatment of arenavirus
#591Chemical Compounds
#592Chiral phase-transfer catalyst and method for preparing alpha-amino acid by using the same
#593Thionyl tetrafluoride modified compounds and uses
#594Substituted quinazoline compounds and methods of use thereof
#595IRE1 small molecule inhibitors
#596Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#597Process for the preparation of umeclidinium bromide
#598Simple process for preparing an intermediate for avibactam
#599Process for preparing an intermediate for avibactam
#600Crystalline forms